Sign in Subscribe
Pharmaceutical industry

Incyte Pharmaceuticals Expands Genomic Database Collaboration with Pfizer

Strategic Insights

— 1 min read

Incyte Pharmaceuticals, Inc., a leading provider of genomic database products, has extended and expanded its collaboration with Pfizer Inc. The agreement, initially announced in 1994, has been extended for an additional three years and now grants Pfizer access to Incyte's full-length gene database, DNA clone set, and continued access to the company's gene sequence and expression database. This partnership is crucial for both companies, as it supports Incyte's scientific goals and enhances Pfizer's capabilities in drug discovery and development.

Key Takeaways:

  • Incyte Pharmaceuticals and Pfizer Inc. have expanded their genomic database collaboration, extending the agreement for an additional three years.
  • The updated agreement grants Pfizer access to Incyte's LifeSeq FL(R) database of full-length genes, the LifeSeq GeneAlbum(TM) DNA clone set, and continued access to the LifeSeq(R) gene sequence and expression database.
  • Incyte has created a portfolio of database products, including LifeSeq(R), LifeSeq Atlas(TM), PathoSeq(TM), LifeSeq FL(R), and ZooSeq(TM), which integrate bioinformatics software with genetic information.
  • These databases support pharmaceutical and biotechnology companies in drug discovery and development, providing information-based tools for research purposes.
  • Incyte's LifeTools(TM) software product line includes data collection, warehousing, data management, statistical analysis, and data mining and visualization capabilities.
  • The collaboration between Incyte and Pfizer has helped Incyte achieve its scientific goals and demonstrates the importance of partnerships in advancing genomic research.

Statistics:

  • The agreement between Incyte Pharmaceuticals and Pfizer Inc. has been extended for an additional three years.
  • Incyte's LifeSeq(R) gene sequence and expression database contains a comprehensive collection of genetic information.
  • The LifeSeq FL(R) database of full-length genes provides a critical resource for pharmaceutical and biotechnology companies in drug discovery and development.

Read more